Diamond Biofund Inc. (TPE:6901)
Taiwan · Delayed Price · Currency is TWD 16.15
-0.40 (-2.42%)
Aug 28, 2026, 1:30 PM CST
Diamond Biofund Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | 3,024 | -1,073 | -2,229 | -2,440 | 1,016 | 3,064 |
| 3,024 | -1,073 | -2,229 | -2,440 | 1,016 | 3,064 | |
Revenue Growth | - | - | - | - | -66.85% | -52.88% |
Gross Profit | 3,024 | -1,073 | -2,229 | -2,440 | 1,016 | 3,064 |
Selling, General & Admin | 120.42 | 119.94 | 152.27 | 148.18 | 101.92 | 64.27 |
Amortization of Goodwill & Intangibles | 0.54 | 0.54 | 0.41 | 0.51 | 0.31 | 0.11 |
Operating Expenses | 147.12 | 147.92 | 180.85 | 158.03 | 113.39 | 76.13 |
Operating Income | 2,877 | -1,221 | -2,410 | -2,598 | 902.24 | 2,988 |
Interest Expense | -2.73 | -3.09 | -3.77 | -0.81 | -0.25 | -0.55 |
Interest & Investment Income | 54.93 | 53.09 | 15.15 | 16.24 | 0.86 | 0.12 |
Other Non Operating Income (Expenses) | -4.87 | -2.64 | 1.85 | -1.7 | -21.74 | -26.56 |
Pretax Income | 2,924 | -1,174 | -2,396 | -2,584 | 881.12 | 2,961 |
Income Tax Expense | - | 0.92 | 121.63 | -0.41 | 83.34 | 108.98 |
Net Income | 2,924 | -1,175 | -2,518 | -2,583 | 797.78 | 2,852 |
Net Income to Common | 2,924 | -1,175 | -2,518 | -2,583 | 797.78 | 2,852 |
Net Income Growth | - | - | - | - | -72.02% | -53.17% |
Shares Outstanding (Basic) | 852 | 852 | 850 | 779 | 749 | 804 |
Shares Outstanding (Diluted) | 861 | 852 | 850 | 779 | 770 | 809 |
Shares Change | 1.17% | 0.18% | 9.19% | 1.21% | -4.90% | 18.16% |
EPS (Basic) | 3.43 | -1.38 | -2.96 | -3.32 | 1.06 | 3.55 |
EPS (Diluted) | 3.39 | -1.38 | -2.96 | -3.32 | 1.04 | 3.52 |
EPS Growth | - | - | - | - | -70.45% | -60.43% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -290.78 | -264.25 | 1,125 | -2,587 | 471.63 | -300.42 |
Free Cash Flow Per Share | -0.34 | -0.31 | 1.32 | -3.32 | 0.61 | -0.37 |
Dividend Per Share | - | - | - | - | 0.170 | 0.200 |
Dividend Growth | - | - | - | - | -15.33% | 0% |
Gross Margin | 100.00% | - | - | - | 100.00% | 100.00% |
Operating Margin | 95.13% | - | - | - | 88.84% | 97.52% |
Profit Margin | 96.70% | - | - | - | 78.55% | 93.08% |
Free Cash Flow Margin | -9.62% | - | - | - | 46.44% | -9.81% |
EBITDA | 2,884 | -1,214 | -2,404 | -2,597 | 903.57 | 2,990 |
EBITDA Margin | 95.37% | - | - | - | 88.97% | 97.59% |
D&A For EBITDA | 7.18 | 7.41 | 5.95 | 1 | 1.33 | 2.31 |
EBIT | 2,877 | -1,221 | -2,410 | -2,598 | 902.24 | 2,988 |
EBIT Margin | 95.13% | - | - | - | 88.84% | 97.52% |
Effective Tax Rate | - | - | - | - | 9.46% | 3.68% |